Seroprevalence of hepatitis a infection in the Turkish Republic of Northern Cyprus

Turkish Journal of Medical Sciences

Volumn 39, Issue 1, 2009, Pages 109-113

  Kurugöl, Zafer ^a   Koturoǧlu, Güldane ^a   Akşit, Sadik ^a   Özacar, Tijen ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

Hepatitis A; Seroprevalence; Turkish Republic of Northern Cyprus

Indexed keywords

AGE GROUPS; CLUSTER SAMPLINGS; HEALTH EDUCATIONS; HEPATITIS A; HEPATITIS A VIRUS; IMMUNE ASSAYS; MASS VACCINATIONS; SEROPREVALENCE; SOCIO-DEMOGRAPHIC CHARACTERISTICS; TURKISH POPULATIONS; TURKISH REPUBLIC OF NORTHERN CYPRUS; WASTE WATERS;

WASTEWATER;

SEWAGE;

HEPATITIS A ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLUSTER ANALYSIS; CONTROLLED STUDY; CYPRUS; EDUCATIONAL STATUS; ENZYME ASSAY; FAMILY SIZE; FEMALE; GROUPS BY AGE; HEPATITIS A; HUMAN; INFANT; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; SEROPREVALENCE; SEWAGE; TURKEY (REPUBLIC); VACCINATION; WASTE WATER;

EID: 63449093201     PISSN: 13000144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. World Health Organization. Hepatitis A. WHO/CDS/CSR/ EDC/2000,7, (available on the internet at http://www.who.int/emc).
2. Melnick JL. History and epidemiology of hepatitis A virus. J Infect Dis 1995; 171(Suppl 1); 2-8.
3. World Health Organization. Hepatitis A vaccines. WHO position paper. Weekly Epidemiological Record 2000; 75: 38-42. (available on the internet at http://www.who.int/wer/pdf/2000/wer7505.pdf.).
4. Lionis C, Frangoulis E, Koulentakis M, Biziagos E, Kouroumalis E. Prevalence of hepatitis A, B, and C markers in school children of a rural area of Crete, Greece. Eur J Epidemiol 1997; 13: 417-20.
5. Dubois F, Thevenas C, Caces E, Vol S, Doctoriarena A, Ecault JL et al. Seroepidemiology of hepatitis A in six departments in West-Central France in 1991. Gastroenterol Clin Biol 1992; 16: 674-9.
6. Gil A, Gonzalez A, Dal-Re R, Ortega P, Dominguez V. Prevalence of antibodies against varicella zoster, herpes simplex (types 1 and 2), hepatitis B and hepatitis A viruses among Spanish adolescents. J infect 1998; 36: 53-6.
7. Moschen ME, Floreani A, Zamparo E, Baldo V, Majori S, Gasparini V et al. Hepatitis A infection: a seroepidemiologicai study in young adults in North-East Italy. Eur J Epidemiol 1997; 13: 875-8.
8. Antunes H, Macedo M, Estrada A. Hepatitis A virus prevalence: Portuguese first results of low endemicity. Acta Med Port 2004; 17: 219-24.
9. Sacy RG, Haddad M, Baasiri G, Khoriati A, Gerbaka BJ, Abu-Elyazeed R. Hepatitis a in Lebanon: a changing epidemiological pattern. Am J Trop Med Hyg 2005; 73: 453-6.
10. Kanra G, Tezcan S, Badur S, Turkish National Study Team. Hepatitis A seroprevalence in a random sample of the Turkish population by simultaneous EPI cluster and comparison with surveys in Turkey. Turk J Pediatr 2002; 44: 204-10.
11. Hadjipanayis A, Hadjichristodoulou C, Kallias M, Sava K, Petsa A, Demetriadou K et al. Prevalence of antibodies to hepatitis A among children and adolescents in Larnaca area, Cyprus. Eur J Epidemiol 1999; 15: 903-5.
12. Rothenberg RB, Lobanov A, Singh KB, Stroh G Jr. Observations on the application of EPI cluster survey methods for estimating disease incidence. Bull World Health Organ 1985; 63: 93-9.
13. Henderson RH, Sundaresan T. Cluster sampling to assess immunization coverage: a review of experience with a simplified sampling method. Bull World Health Organ 1982; 60: 253-60.
14. Sidal M, Unuvar E, Oguz F, Cihan C, Onel D, Badur S, Age-specific seroepidemiology of hepatitis A, B, and E infections among children in Istanbul, Turkey. Eur J Epidemiol 2001; 17: 141-4.
15. Vançelik S, Güraksin A, Alp H. Hepatitis A seroepidemiology in Eastern Turkey. East Afr Med J 2006; 83: 86-90.
16. Erdogan MS, Oktun M, Tatman-Oktun M, Akata F, Türe M. The epidemiology of hepatitis a virus infection in children, in Edirne, Turkey. Eur J Epidemiol 2004; 19: 267-73.
17. Mossong J, Putz L, Patiny S, Schneider F. Seroepidemiology of hepatitis A and hepatitis B virus in Luxembourg. Epidemiol Infect 2006; 134: 808-13.
18. Beran J, Douda P, Rychly R. Seroprevalence of viral hepatitis A in the Czech Republic. Eur J Epidemiol 1999; 15: 805-8.
19. Termorshuizen F, Dorigo-Zetsma JW, de Melker HE, van den Hof S, Conyn-Van Spaendonck MA. The prevalence of antibodies to hepatitis A virus and its determinants in The Netherlands: a population-based survey. Epidemiol Infect 2000; 124: 459-66.
20. Bell BP, Kruszon-Moran D, Shapiro CN, Lambert SB, McQuillan GM, Margolis HS. Hepatitis A virus infection in the United States: serologic results from the Third National Health and Nutrition Examination Survey. Vaccine 2005; 23: 5798-806.
21. Letaief A, Kaabia N, Gaha R, Bousaadia A, Lazrag F, Trabelsi H et al. Age-specific seroprevalence of hepatitis a among school children in central Tunisia. Am J Trop Med Hyg 2005; 73: 40-3.
22. de Silva KS, Weerasuriya DC, Peelawattage M, Fernando S. Seroprevalence of hepatitis A antibodies in relation to social factors-a preliminary study. Ceylon Med J 2005; 50: 54-8.
23. Mall ML, Rai RR, Philip M, Naik G, Parekh P, Bhawnani SC et al. Seroepidemiology of hepatitis A infection in India: changing pattern. Indian J Gastroenterol 2001 ; 20: 132-5.
24. Mehr AJ, Ardakani MJ, Hedayati M, Shahraz S, Mehr EJ, Zali MR. Age-specific seroprevalence of hepatitis A infection among children visited in pediatric hospitals of Tehran, Iran. Eur J Epidemiol 2004; 19: 275-8.
25. Lin JB, Lin DB, Chen SC, Chen PS, Chen WK. Seroepidemiology of hepatitis A, B, C, and E viruses infection among preschool children in Taiwan. J Med Virol 2006; 78: 18-23.
26. Fix AD, Martin OS, Gallicchiol L, Vial PA, Lagos R. Age specific prevalence of antibodies to hepatitis A in Santiago, Chile: risk factors and shift in age of infection among children and young adults. Am J Trop Med Hyg 2002; 66: 628-32.
27. Tanaka J. Hepatitis A shifting epidemiology in Latin America. Vaccine 2000; 18 (Suppl 1): 57-60.
28. Anis E, Leventhal A, Roitman M, Slater PE. Introduction of routine hepatitis A immunization in Israel-the first in the world. Harefuah 2000; 138: 177-80.